510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K093129Substantially Equivalent

Illumina Verncode Genotyping Test for Facor V and Factor II

Illumina, Inc., San Diego CA / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K093129 is the FDA 510(k) clearance record for ILLUMINA VERNCODE GENOTYPING TEST FOR FACOR V AND FACTOR II, a class II device, cleared for Illumina, Inc. on under FDA product code NPQ (Test, Factor V Leiden Mutations, Genomic Dna Pcr). FDA's definition for product code NPQ reads: "In vitro diagnostic test to detect the Factor V Leiden mutation in genomic DNA, as an aid to diagnosis in the evaluation of patients with suspected thrombophilia". FDA records list 6 510(k) clearances for Illumina, Inc., from to . As of , FDA records show no recalls naming K093129.

Clearance record

Decision date
Received
(208 days to decision)
Product code
NPQ Test, Factor V Leiden Mutations, Genomic Dna Pcr
Regulation
21 CFR 864.7280
Device class
Class II
Review panel
Hematology
Applicant
Illumina, Inc. 9865 Towne Centre Dr., San Diego CA
510(k) summary
Statement
Third party review
No

Clearances, product code NPQ

Trailing 12 months

FDA records hold no clearances under product code NPQ in the trailing twelve months.

FDA records show no clearances under product code NPQ in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code NPQ, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260